Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00769821 · ClinicalTrials.gov registry record
The Impact of Lymphedema on Breast Cancer Survivors
A clinical trial of Breast Cancer and Lymphedema, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 145
- Enrollment target
- 1
- Study location
NCT00769821 is a study of Breast Cancer and Lymphedema that has completed, run by University of California, San Francisco. The registered enrollment target is 145 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00769821, a study of Breast Cancer and Lymphedema, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 145 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Gathering information from breast cancer survivors about lymphedema; its symptoms and their impact on shoulder, arm, and hand functioning; and quality of life may help doctors learn more about the disease. PURPOSE: This clinical trial is studying the impact of lymphedema on breast cancer survivors.
Conditions Studied
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- PROCEDURE assessment of therapy complications
- PROCEDURE bioimpedance spectroscopy
Study Locations (1)
California
- University of California, San Francisco School of Nursing - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2007-02 |
| Est. Completion | 2009-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00769821
The ClinicalTrials.gov registry entry for NCT00769821 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which questionnaire administration is the first listed.
NCT00769821 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00769821 about?
NCT00769821 is a clinical study titled "The Impact of Lymphedema on Breast Cancer Survivors". RATIONALE: Gathering information from breast cancer survivors about lymphedema; its symptoms and their impact on shoulder, arm, and hand functioning; and quality of life may help doctors learn more about the disease. PURPOSE: This clinical trial is studying the impact of lymphedema on breast cancer...
What is the current status of trial NCT00769821?
This trial is currently completed. The enrollment target is 145 participants. The study started on 2007-02. Estimated completion is 2009-02.
What conditions does trial NCT00769821 study?
This clinical trial studies the following conditions: Breast Cancer, Lymphedema, Cancer Survivor, Perioperative/Postoperative Complications.
What interventions are being tested in trial NCT00769821?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), assessment of therapy complications (PROCEDURE), bioimpedance spectroscopy (PROCEDURE).
Who is sponsoring clinical trial NCT00769821?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00769821 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.